RESEARCH PAPER
Are agricultural and natural sources of bio-products important for modern regenerative medicine? A review
1
Chair and Department of Surgical Oncology, Nicolaus Copernicus University in Torun, Ludwik Rydygier Medical College, The Prof. F. Łukaszczyk Memorial Oncology Centre in Bydgoszcz, Poland
2
Chair of Cosmetology and Aesthetic Dermatology, Nicolaus Copernicus University in Torun, Ludwik Rydygier Medical College in Bydgoszcz, Polan
3
Chair of Urology, Department of Regenerative Medicine, Nicolaus Copernicus University in Torun, Ludwik Rydygier Medical College in Bydgoszcz, Poland
Corresponding author
Tomasz Kloskowski
Chair of Urology, Department of Regenerative Medicine, Nicolaus Copernicus University in Torun, Ludwik Rydygier Medical College in Bydgoszcz, Poland
Chair of Urology, Department of Regenerative Medicine, Nicolaus Copernicus University in Torun, Ludwik Rydygier Medical College in Bydgoszcz, Poland
Ann Agric Environ Med. 2017;24(2):207–212
KEYWORDS
Celluloseplant extractAlginatechitosanporcine scaffoldsmall intestine submusocsa (SIS)bladder acellular matrix (BAM)
ABSTRACT
Introduction and objectives:
As tissue engineering and regenerative medicine have continued to evolve within the field of biomedicine, the fundamental importance of bio-products has become increasingly apparent. This true not only in cases where they are derived directly from the natural environment, but also when animals and plants are specially bred and cultivated for their production.
Objective:
The study aims to present and assess the global influence and importance of selected bio-products in current regenerative medicine via a broad review of the existing literature. In particular, attention is paid to the matrices, substances and grafts created from plants and animals which could potentially be used in experimental and clinical regeneration, or in reconstructive procedures.
Summary:
Evolving trends in agriculture are likely to play a key role in the future development of a number of systemic and local medical procedures within tissue engineering and regenerative medicine. This is in addition to the use of bio-products derived from the natural environment which are found to deliver positive results in the treatment of prospective patients.
As tissue engineering and regenerative medicine have continued to evolve within the field of biomedicine, the fundamental importance of bio-products has become increasingly apparent. This true not only in cases where they are derived directly from the natural environment, but also when animals and plants are specially bred and cultivated for their production.
Objective:
The study aims to present and assess the global influence and importance of selected bio-products in current regenerative medicine via a broad review of the existing literature. In particular, attention is paid to the matrices, substances and grafts created from plants and animals which could potentially be used in experimental and clinical regeneration, or in reconstructive procedures.
Summary:
Evolving trends in agriculture are likely to play a key role in the future development of a number of systemic and local medical procedures within tissue engineering and regenerative medicine. This is in addition to the use of bio-products derived from the natural environment which are found to deliver positive results in the treatment of prospective patients.
REFERENCES (50)
1.
Ji HF, Li XJ, Zhang HY. Natural products and drug discovery. Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia? EMBO Rep. 2009; 10(3): 194–200.
2.
Petrovska BB. Historical review of medicinal plants’ usage. Pharmacogn Rev. 2012; 6(11): 1–5.
3.
Rosenfeld L. Insulin: discovery and controversy. Clin Chem. 2002; 48(12): 2270–2288.
4.
Pushkar D, Kasyan G, Gvozdev M, Sosnowski R. Analysis of 1,000 cases of synthetic midurethral slings used for treatment of female urinary incontinence – a single-center experience. Cent European J Urol. 2011; 64(4): 243–251.
5.
Nowacki M, Adamowicz J, Pietkun K, Olkowska J, Kloskowski T, Bajek A, et al. Non-alcoholic beverages, unknown influence on cell proliferation – an in vitro study. Ann Agric Environ Med. 2014; 21(1): 113.
6.
Adamowicz J, Kowalczyk T, Drewa T. Tissue engineering of urinary bladder – current state of art and future perspectives. Cent European J Urol. 2013; 66(2): 202–206.
7.
Kloskowski T, Kowalczyk T, Nowacki M, Drewa T. Tissue engineering and ureter regeneration: is it possible? Int J Artif Organs. 2013; 36(6): 392–405.
8.
Spector M. The tissue engineer’s toolbox manifesto. Biomed Mater. 2014; 9(1): 010201.
9.
Panda NN, Jonnalagadda S, Pramanik K. Development and evaluation of cross-linked collagen-hydroxyapatite scaffolds for tissue engineering. J Biomater Sci Polym Ed. 2013; 24(18): 2031–2044.
10.
Bačáková L, Novotná K, Pařízek M. Polysaccharides as Cell Carriers for Tissue Engineering: the Use of Cellulose in Vascular Wall Reconstruction. Physiol Res. 2014; 63(Suppl. 1): S29-S47.
11.
Fu L, Zhang J, Yang G. Present status and applications of bacterial cellulose-based materials for skin tissue repair. Carbohydr Polym. 2013; 92(2): 1432–1442.
12.
Zang S, Zhuo Q, Chang X, Qiu G, Wu Z, Yang G. Study of osteogenic differentiation of human adipose-derived stemcells (HASCs) on bacterial cellulose. Carbohydr Polym. 2014; 104: 158–165.
13.
Shah N, Ul-Islam M, Khattak WA, Park JK. Overview of bacterial cellulose composites: A multipurpose advanced material. Carbohydr Polym. 2013; 98(2): 1585–1598.
14.
Novaes AB, Novaes AB, Grisi MFM, Soares UN, Gabarra F. Gengiflex, an Alkali-Cellulose Membrane for GTR: Histologic Observations. Braz Dent J. 1993; 4(2): 65–71.
15.
Pokrywczynska M, Adamowicz J, Sharma AK, Drewa T. Human urinary bladder regeneration through tissue engineering – An analysis of 131 clinical cases. Exp Biol Med (Maywood). 2014; 239(3): 264–271.
16.
Bidarra SJ, Barrias CC, Granja PL. Injectable alginate hydrogels for cell delivery in tissue engineering. Acta Biomater. 2014; 10(4): 1646–1662.
17.
Aroguz AZ, Baysal K, Adiguzel Z, Baysal BM. Alginate/Polyoxy ethylene and Alginate/Gelatin Hydrogels: Preparation, Characterization, and Application inTissue Engineering. Appl Biochem Biotechnol. 2014; 173(2): 433–448.
18.
Kemp P. History of regenerative medicine: looking backwards to move forwards. Regen Med. 2006; 1(5): 653–669.
19.
Lin L, Perets A, Har-El YE, Varma D, Li M, Lazarovici P, et al. Alimentary ‘green’ proteins as electrospun scaffolds for skin regenerative engineering. J Tissue Eng Regen Med. 2013; 7(12): 994–1008.
20.
Shin M, Yoshimoto H, Vacanti JP. In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng. 2004; 10(1–2): 33–41.
21.
Czajkowski R, Pokrywczynska M, Placek W, Zegarska B, Tadrowski T, Drewa T. Transplantation of cultured autologous melanocytes: hope or danger? Cell Transplant. 2010; 19(5): 639–643.
22.
Farias DF, Souza TM, Viana MP, Soares BM, Cunha AP, Vasconcelos IM, et al. Antibacterial, antioxidant, and anticholinesterase activities of plant seed extracts from Brazilian semiarid region. Biomed Res Int. 2013; 2013: 510736.
23.
Jayakumar R, Prabaharan M, Nair SV, Tamura H. Novel chitin and chitosan nanofibers in biomedical applications. Biotechnol Adv. 2010; 28(1): 142–150.
24.
Chandy T, Sharma CP. Chitosan-as a biomaterial. Artif Cells Nanomedicine Biotechnol. 1990; 18(1): 1–24.
25.
Illum, L. Chitosan and its use as a pharmaceutical excipient. Pharm Res. 1998; 15(9): 1326–1331.
26.
Sliva SS, Mano JF, Reis RL. Potential applications of natural origin polymer-based systems in soft tissue regeneration. Crit Rev Biotechnol. 2010; 30(3): 200–221.
27.
Drewa T, Adamowicz J, Lysik J, Polaczek J, Pielichowski J. Chitosan scaffold enhances nerve regeneration within the in vitro reconstructed bladder wall: an animal study. Urol Int. 2008; 81(3): 330–334.
28.
Adewuyi S, Kareem KT, Atayese AO, Amolegbe SA, Akinremi CA. Chitosan-cobalt (II) and nickel (II) chelates as antibacterial agents. Int J Biol Macromol. 2011; 48(2): 301–303.
29.
Xiong Y, Chan WY, Chua AW, Feng J, Gopal P, Ong YS, et al. Decellularized porcine saphenous artery for small-diameter tissue-engineered conduit graft. Artif Organs. 2013; 37(6): E74–87.
30.
Fitzpatrick JC, Clark PM, Capaldi FM. Effect of decellularization protocol on the mechanical behavior of porcine descending aorta. Int J Biomater. 2010; 2010.
31.
Hsu PW, Salgado CJ, Kent K, Finnegan M, Pello M, Simons R, et al. Evaluation of porcine dermal collagen (Permacol) used in abdominal wall reconstruction. J Plast Reconstr Aesthet Surg. 2009; 62(11): 1484–1489.
32.
Smart NJ, Bryan N, Hunt JA, Daniels IR. Porcine dermis implants in soft-tissue reconstruction: current status. Biologics. 2014; 8: 83–90.
33.
Badylak SF, Lantz GC, Coffey A, Geddes LA. Small intestinal submucosa as a large diameter vascular graft in the dog. J Surg Res. 1989; 47(1): 74–80.
34.
Gilbert TW, Sellaro TL, Badylak SF. Decellularization of tissues and organs. Biomaterials. 2006; 27(19): 3675–3683.
35.
Hung SH, Su CH, Lee FP, Tseng H. Larynx decellularization: combining freeze-drying and sonication as an effective method. J Voice. 2013; 27(3): 289–294.
36.
Dahl SL, Koh J, Prabhakar V, Niklason LE. Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant. 2003; 12(6): 659–666.
37.
Luo JC, Chen W, Chen XH, Qin TW, Huang YC, Xie HQ, et al. A multi-step method for preparation of porcine small intestinal submucosa (SIS). Biomaterials. 2011; 32(3): 706–713.
38.
Brown B, Lindberg K, Reing J, Stolz DB, Badylak SF. The basement membrane component of biologic scaffolds derived from extracellular matrix. Tissue Eng. 2006; 12(3): 519–526.
39.
Nakatsu H, Ueno T, Oga A, Nakao M, Nishimura T, Kobayashi S, et al. Influence of mesenchymal stem cells on stomach tissue engineering using small intestinal submucosa. J Tissue Eng Regen Med. 2013; 9(3): 296–304.
40.
Shukla D, Box GN, Edwards RA, Tyson DR. Bone marrow stem cells for urologic tissue engineering, World J Urol. 2008; 26(4): 341–349.
41.
Zhou Y, Yan Z, Zhang H, Lu W, Liu S, Huang X, et al. Expansion and delivery of adiposederived mesenchymal stem cells on three microcarriers for soft tissue regeneration. Tissue Eng Part A. 2011; 17(23–24): 2981–2997.
42.
Drewa T, Joachimiak R, Kaznica A, Sarafian V, Pokrywczynska M. Hair stem cells for bladder regeneration in rats: preliminary results. Transplant Proc. 2009; 41(10): 4345–4351.
43.
Li CL, Liao WB, Yang SX, Song C, Li YW, Xiong YH, et al. Urethral reconstruction using bone marrow mesenchymal stem cell- and smooth muscle cell-seeded bladder acellular matrix. Transplant Proc. 2013; 45(9): 3402–3407.
44.
Brown AL, Brook-Allred TT, Waddell JE, White J, Werkmeister JA, Ramshaw JA, Bagli DJ, Woodhouse KA, Bladder acellular matrix as a substrate for studying in vitro bladder smooth muscle-urothelial cell interactions, Biomaterials. 2005 Feb; 26(5): 529–43.
45.
Davis NF, Callanan A, McGuire BB, Flood HD, McGloughlin TM. Evaluation of viability and proliferative activity of human urothelial cells cultured onto xenogenic tissue-engineered extracellular matrices, Urology. 2011; 77(4): 1007.e1–7.
46.
Chun SY, Lim GJ, Kwon TG, Kwak EK, Kim BW, Atala A, et al. Identification and characterization of bioactive factors in bladder submucosa matrix, Biomaterials. 2007; 28(29): 4251–4256.
47.
Bajek A, Drewa T, Joachimiak R, Marszałek A, Gagat M, Grzanka A. Stem cells for urinary tract regeneration. Cent European J Urol. 2012; 65(1): 7–10.
48.
Polak DJ. Regenerative medicine. Opportunities and challenges: a brief overview. J R Soc Interface. 2010; 7(Suppl 6): S777–781.
49.
Mano JF, Silva GA, Azevedo HS, Malafaya PB, Sousa RA, Silva SS, et al. Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends. J R Soc Interface. 2007; 4(17): 999–1030.
50.
Nowacki M, Kloskowski T, Pokrywczyńska M, Nazarewski L, Jundziłł A, Pietkun K, et al. Is regenerative medicine a new hope for kidney replacement? J Artif Organs. 2014; 17(2): 123–134.
Improvement of visual identification of the journal - task financed under the agreement No. 618/P-DUN/2019 by the Minister of Science and Higher Education allocated to the activities of disseminating science.
Generation of the DOI (Digital Object Identifier) - task financed under the agreement No. 618/P-DUN/2019 by the Minister of Science and Higher
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.